EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugsCNBC • 07/11/23
EU medicines regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harmMarket Watch • 07/11/23
The Damaging Report That Sent Weight-Loss Kingpins Novo Nordisk, Eli Lilly Into A TailspinInvestors Business Daily • 07/11/23
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group saysCNBC • 06/30/23
Eli Lilly Sets New Bar In Weight Loss And Nears Record High; Novo Nordisk SlipsInvestors Business Daily • 06/27/23
Novo Nordisk to seek approval for oral version of top-selling weight loss treatmentProactive Investors • 06/26/23
Novo Nordisk says obesity pill leads to 15% weight loss; availability "to be determined"Reuters • 06/26/23
Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trialsGlobeNewsWire • 06/24/23